The Environmental Impact of CGM Devices: A Pharmacist’s Perspective

A woman wearing a continuous glucose monitor on her arm.

Continuous glucose monitoring (CGM) technology has revolutionized diabetes care, offering patients a more convenient and insightful way to manage their blood glucose levels. However, the increasing use of these devices raises concerns about their environmental footprint. This article examines the potential environmental impacts of CGM devices, from production and resource consumption to disposal, and explores how pharmacists can contribute to more sustainable practices.

A woman wearing a continuous glucose monitor on her arm.A woman wearing a continuous glucose monitor on her arm.

The CGM Lifecycle and its Environmental Costs

Each stage of a CGM’s battery lifecycle presents potential environmental challenges. The production process, the resources used, and the eventual disposal all contribute to the device’s carbon footprint. A recent analysis published in the Journal of Diabetes and Science Technology, using data from the International Energy Agency (IEA), highlights these concerns.

Battery Production: A Closer Look

Two primary battery systems power most CGMs: zinc-silver oxide (used in Freestyle Libre sensors and Omnipod pumps) and lithium metal-manganese dioxide (used in Dexcom sensors). The extraction of both lithium and silver carries significant environmental risks.

Lithium mining, for example, is water-intensive, consuming approximately 1900 tons of water per ton of lithium extracted. This can deplete local water resources, impacting surrounding ecosystems. Silver extraction often involves the use of corrosive chemicals like cyanides and ferricyanides, which pose contamination risks to water and soil. Historical incidents, such as a major spill that affected Hungary, Romania, and Yugoslavia, demonstrate the devastating consequences of such contamination.

See also  Aripiprazole Oral Solution: A Comprehensive Guide

CGM Disposal: Navigating the Challenges

The improper disposal of CGM batteries adds another layer of complexity. Incinerating zinc-silver dioxide batteries can release harmful gasses, posing health risks. When disposed of in landfills, heavy metals like silver can leach into groundwater, contaminating valuable water resources. Lithium-manganese dioxide batteries are particularly problematic due to their reactivity with air and water, creating a fire hazard if not handled correctly.

The Pharmacist’s Role in Promoting Sustainable CGM Use

Pharmacists are uniquely positioned to educate patients and advocate for more environmentally conscious practices surrounding CGM use. Here’s how they can make a difference:

Promoting Take-Back Programs

Pharmacists can inform patients about sensor kit and pod take-back programs. These programs ensure that used devices are sent to specialized waste-to-energy facilities, diverting them from landfills. Abbott’s Freestyle program is one example of such an initiative.

Recommending Rechargeable Devices

Pharmacists can encourage the use of CGMs with rechargeable batteries, reducing the reliance on single-use primary batteries. The Medtronic Guardian transmitter, for instance, requires only weekly charging and has a battery lifespan of approximately one year.

Exploring Reusable Smart Insulin Pens

For patients using multiple daily injections, reusable smart insulin pens offer a sustainable alternative. The NovoPen by Novo Nordisk, for example, features a lithium battery that lasts for several years.

A Call for Continued Progress

While CGM technology represents a significant advancement in diabetes management, addressing the environmental impact of these devices is crucial for long-term sustainability. By actively promoting responsible disposal practices and advocating for eco-friendly alternatives, pharmacists can play a key role in minimizing the environmental burden associated with CGM technology. For personalized treatment plans and further guidance on sustainable CGM practices, consult with a healthcare professional.

See also  Managing Cardiotoxicity Risks in Cancer Treatment: A Pharmacist's Perspective